Mylotarg

In the US, Mylotarg (gemtuzumab systemic) is a member of the drug class CD33 monoclonal antibodies and is used to treat Acute Myeloid Leukemia.

US matches:

• Mylotarg

Ingredient matches for Mylotarg

Gemtuzumab

Gemtuzumab ozogamicin (a derivative of Gemtuzumab) is reported as an ingredient of Mylotarg in the following countries:

• Argentina


• Colombia


• Japan


• Switzerland


• United States


• Venezuela

International Drug Name Search